tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market
KYMR
Kymera Therapeutics
RESEARCH TOOLSreports

Kymera Therapeutics (KYMR) Stock News & Sentiment

Compare
406 Followers
Kymera Therapeutics Announces Major Stock Offering
Premium
Company Announcements
Kymera Therapeutics Announces Major Stock Offering
27d ago
8K
KYMR
Kymera Therapeutics’ KT-621: Promising Oral Treatment for Atopic Dermatitis and Asthma Expansion Potential
Premium
Ratings
Kymera Therapeutics’ KT-621: Promising Oral Treatment for Atopic Dermatitis and Asthma Expansion Potential
29d ago
KYMR
Kymera Therapeutics: Promising Phase 1b Trial Results and Competitive Edge Drive Buy Rating
Premium
Ratings
Kymera Therapeutics: Promising Phase 1b Trial Results and Competitive Edge Drive Buy Rating
29d ago
KYMR
Promising Potential of Kymera Therapeutics’ KT-621: A Buy Rating Justified by Strong Clinical Trial Results
Premium
Ratings
Promising Potential of Kymera Therapeutics’ KT-621: A Buy Rating Justified by Strong Clinical Trial Results
29d ago
KYMR
Kymera Therapeutics’ KT-621: Promising Market Potential and Competitive Positioning in Atopic Dermatitis Treatment
Premium
Ratings
Kymera Therapeutics’ KT-621: Promising Market Potential and Competitive Positioning in Atopic Dermatitis Treatment
29d ago
KYMR
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
29d ago
K
CMG
Kymera Therapeutics (KYMR) Stock Surges on Surprisingly Strong Clinical Trial Results
Premium
Market News
Kymera Therapeutics (KYMR) Stock Surges on Surprisingly Strong Clinical Trial Results
30d ago
KYMR
More KYMR News >

KYMR News on the Web

Kymera Therapeutics Sets Stage for Major 2026 Pipeline Updates at J.P. Morgan Healthcare Conference
Market Chameleon
Neutral
KYMR Skyrockets 82.4% in a Year: More Upside Potential in 2026?
Zacks
Bullish
Why Kymera Therapeutics, Inc.’s (KYMR) Stock Is Down 5.80%
AAII
Neutral
Why Kymera Therapeutics, Inc.’s (KYMR) Stock Is Up 5.06%
AAII
Neutral
Kymera Therapeutics (KYMR) Gets a Buy from Wells Fargo
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Fulcrum Therapeutics (FULC) and Novan (NOVN)
TipRanks News
Neutral
Why Kymera Therapeutics, Inc.’s (KYMR) Stock Is Down 5.01%
AAII
Neutral
Kymera's Eczema Drug Gets Fast Track Designation in the United States
Zacks
Bullish

News Score - Last 7 Days

Neutral
KYMR
Sector Average
Media Buzz
This Week3 articles
Weekly Average2.25 articles
News Sentiment
This Week100%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KYMR’s Media Buzz Sentiment?
3 articles about KYMR were published this week. In an average week, 2.25 articles are published.
    What is KYMR’s weekly average amount of articles?
    In an average week, 2.25 articles about KYMR are published.
      What is KYMR’s News Sentiment?
      100% of articles about KYMR were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        ARDXArdelyx
        IRWDIronwood Pharma
        REGNRegeneron
        NBPNovaBridge Biosciences
        TILInstil Bio
        Showing the stocks with the most bullish news sentiment over the past week